A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Clinical trial NCT05011097 · COMPLETED

Trial details

NCT number: NCT05011097
Sponsor: Wuhan YZY Biopharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Multiple Myeloma

Start date: 2021-07-08
Primary completion: 2023-10-23
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.